Baird Maintains Acadia Healthcare Company Inc to Outperform with Price Target $66.00

Brokerage firm Baird Maintains its rating on Acadia Healthcare Company Inc(NASDAQ:ACHC). In a research note issued to the investors, the brokerage major Lowers the price-target to $66.00 per share. The shares have been rated Outperform. The rating by Baird was issued on Sep 15, 2016.

Acadia Healthcare Company Inc (ACHC) shares turned negative on Tuesdays trading session with the shares closing down -0.83 points or -1.63% at a volume of 11,62,062. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $51.0907. The peak price level was also seen at $51.0907 while the days lowest was $49.82. Finally the shares closed at $50.2. The 52-week high of the shares is $76.91 while the 52-week low is $48.05. According to the latest information available, the market cap of the company is $4,388 M.

Acadia Healthcare Company Inc(ACHC) last announced its earnings results on Jul 29, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $756.55M. Analysts had an estimated revenue of $752.57M. Earnings per share were $0.73. Analysts had estimated an EPS of $0.73.

Several Insider Transactions has been reported to the SEC. On Sep 14, 2016, Reeve B Waud (director 10% owner) sold 84,208 shares at $51.50 per share price.Also, On Aug 17, 2016, David M. Duckworth (Chief Financial Officer) sold 16,670 shares at $54.33 per share price.On Aug 15, 2016, Ronald Morgan Fincher (Chief Operating Officer) sold 14,604 shares at $52.50 per share price, according to the Form-4 filing with the securities and exchange commission.

Acadia Healthcare Company Inc. is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities residential treatment centers group homes substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities. It operates in two segments: U.S. Facilities and U.K. Facilities. Its U.S. Facilities and services are classified into categories which includes acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. In the United Kingdom it provides inpatient services through mental health hospitals and care homes. In addition to these services it also operates a U.K. division to provide EAP to organizations. The Company operated approximately 78 behavioral healthcare facilities with over 5800 beds in approximately 24 states the United Kingdom and Puerto Rico.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Acadia Healthcare Company Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Acadia Healthcare Company Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.